Hyderabad, India -- (SBWIRE) -- 02/19/2018 -- The report on " Prostate Cancer Market by Diagnostic Techniques (Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA)), by Surgery (Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR)), by Radiation Therapy (External Beam Radiation Therapy (3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy) and Brachytherapy (Permanent Brachytherapy and Temporary Brachytherapy)), by Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", is published by Market Data Forecast. The Global Prostate Cancer Market was priced $48 billion in 2016 and calculable to be growing at a CAGR of 9.5% to achieve $75.56 billion by 2021, within the mentioned forecast period. The cancer cells may spread from the prostate to the parts of the body, through the bones and humor nodes. In later stages of cancer, it can cause difficulty in urination, blood in the piss, etc. Old age, family history and race are a number of the factors that increase the chance of prostate cancer. Prostate cancer is most of the times diagnosed by diagnostic test. The prostate cancer market contains a high demand for original medicine that focuses on unmet desires like less toxicity, higher progression free survival, lesser price, improved effectiveness, and improved survival time.

Browse through 179 Pages and in-depth TOC on "Prostate Cancer Market"
https://www.marketdataforecast.com/market-reports/global-prostate-cancer-market-1616/

The Global Prostate cancer Market is principally driven by factors like Enhanced diagnosis, sterilisation mode, and increasing awareness among individuals, investments into drug development, strong emerging pipeline, technological advancements in researching for brand new techniques to fight with prostate cancer and huge incidence rates in developed economies.

However, the high price of treatment, prolonged treatment durations, side effects of surgery like urinary incontinence, blood clots, impotence, stroke, and surgical risks like heart failure are impeding the growth of the market.

Customized Report: https://www.marketdataforecast.com/market-reports/global-prostate-cancer-market-1616/customize-report

The fragmentation of Global Prostate cancer Market is done on the basis of diagnostic techniques, Radiation therapy, Chemotherapy, and surgery. On the idea of Radiation Therapy, the Global Prostate cancer Market is classified as External Beam Radiation Therapy and Brachytherapy. Brachytherapy segment is classified as Permanent Brachytherapy and Temporary Brachytherapy. External bean radiation therapy segment is again subdivided into Proton Beam Radiation Therapy, 3D Conformal Radiation Therapy, Stereotactic Body Radiation Therapy, and Intensity Modulated Radiation Therapy. On the origin of surgery, the market is bifurcated into Orchidectomy and Trans Urethral Resection (TUR), Radical Prostatectomy. On the source of diagnostic techniques, the Prostate cancer Market is categorized as Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA).On the base of chemotherapy, the market is segmented into Docetaxel, Vinblastine, Vinorelbine, Etoposide, and Carboplatin.

Request Sample: https://www.marketdataforecast.com/market-reports/global-prostate-cancer-market-1616/request-sample

On the theory of geographical analysis, the worldwide Prostate cancer Market is classified into varied regions namely Middle East, North America, Europe, Latin America, and Asia-Pacific, Africa. North America region holds the biggest share of the world prostate cancer market. However, Asia-Pacific and Latin America are calculable to record the best CAGR throughout the forecast period.

Some of the major companies dominating the Prostate cancer Market are Johnson & Johnson, Sanofi S.A, Genentech, Varian Medical Systems, Pfizer, GlaxoSmithKline, Abbott Laboratories, Theragenics, AstraZeneca, Bayer, Novartis, AbbVie, Roche, and Elekta.

About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

Related Link:
https://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626